Sánchez-Palestino, L.M.; Moreno-RodrÃguez, A.; Navarrete-Carriola, D.V.; MartÃnez-Archundia, M.; López-Vargas, M.; Argueta-Figueroa, L.; Vázquez-Jiménez, L.K.; Paz-González, A.D.; Ortiz-Pérez, E.; Doyle, M.P.;
et al. Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents. Pharmaceutics 2025, 17, 1271.
https://doi.org/10.3390/pharmaceutics17101271
AMA Style
Sánchez-Palestino LM, Moreno-RodrÃguez A, Navarrete-Carriola DV, MartÃnez-Archundia M, López-Vargas M, Argueta-Figueroa L, Vázquez-Jiménez LK, Paz-González AD, Ortiz-Pérez E, Doyle MP,
et al. Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents. Pharmaceutics. 2025; 17(10):1271.
https://doi.org/10.3390/pharmaceutics17101271
Chicago/Turabian Style
Sánchez-Palestino, Luis M., Adriana Moreno-RodrÃguez, Diana V. Navarrete-Carriola, Marlet MartÃnez-Archundia, Marhian López-Vargas, Liliana Argueta-Figueroa, Lenci K. Vázquez-Jiménez, Alma D. Paz-González, Eyra Ortiz-Pérez, Michael P. Doyle,
and et al. 2025. "Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents" Pharmaceutics 17, no. 10: 1271.
https://doi.org/10.3390/pharmaceutics17101271
APA Style
Sánchez-Palestino, L. M., Moreno-RodrÃguez, A., Navarrete-Carriola, D. V., MartÃnez-Archundia, M., López-Vargas, M., Argueta-Figueroa, L., Vázquez-Jiménez, L. K., Paz-González, A. D., Ortiz-Pérez, E., Doyle, M. P., & Rivera, G.
(2025). Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents. Pharmaceutics, 17(10), 1271.
https://doi.org/10.3390/pharmaceutics17101271
